Tag: Janssen

The FINANCIAL -- The World Health Organization (WHO) listed the COVID-19 vaccine Ad26.COV2.S, developed by Janssen (Johnson & Johnson), for ...

The FINANCIAL -- The Phase 3 ENSEMBLE study of the single-dose regimen of JNJ-78436735, the investigational vaccine candidate for the ...

The FINANCIAL -- Global pharmaceutical company Janssen will begin clinical trials of its potential vaccine in the UK from today ...

The FINANCIAL -- Johnson & Johnson (NYSE: JNJ) (the Company) today announced the European Commission (EC), acting on behalf of ...